Bionano Reports First Quarter 2023 Results and Highlights Recent Business Progress
09. Mai 2023 16:01 ET
|
Bionano Genomics
Q1 2023 revenue was $7.4 million, which represents a 30% increase over Q1 2022Installed base of 259 Saphyr® systems totaled as of Q1 2023, which represents a 47% increase over Q1 2022Sold 5,226...
Bionano Announces the Publication of Stockholder Letter Regarding Support for Proxy Proposal
01. Mai 2023 19:50 ET
|
Bionano Genomics
SAN DIEGO, May 01, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), today announced that on May 1, 2023, it published an open letter to stockholders in support of its proposals at its...
Bionano Announces Three Publications Demonstrating OGM’s Utility for Hematological Malignancy Research
26. April 2023 08:00 ET
|
Bionano Genomics
Three peer-reviewed publications collectively illustrate the building support in Europe for optical genome mapping (OGM) as a powerful alternative to traditional methods of cytogenetic analysis for...
UPDATE - Bionano Announces Preliminary Q1 2023 Results and Business Updates
24. April 2023 09:54 ET
|
Bionano Genomics
Preliminary Q1 total revenue expected to be between $7.3 and $7.5 million, which would represent an estimated increase of 28% to 32% over Q1 2022Installed base of Saphyr® systems reached 259 as of...
Bionano Announces Preliminary Q1 2023 Results and Business Updates
24. April 2023 08:00 ET
|
Bionano Genomics
Preliminary Q1 total revenue expected to be between $7.3 and $7.5 million, which would represent an estimated increase of 28% to 32% over Q1 2022Installed base of Saphyr® systems reached 259 as of...
Bionano Announces Presentation of OGM Utility Across Cancer Genomics Research Applications at the American Association for Cancer Research (AACR) Annual Meeting
13. April 2023 16:01 ET
|
Bionano Genomics
A sponsored session will feature Dr. Ben Finlay from Sanford Burnham Prebys Institute, Dr. Marc Henri Stern from Institut Curie and Dr. Rashmi Kanagal-Shamanna from MD Anderson Cancer Center...
Bionano Announces Publication that Demonstrates OGM’s Utility for Resolving Complex Genetic Variation in Inherited Retinal Disease
06. April 2023 08:00 ET
|
Bionano Genomics
SAN DIEGO, April 06, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study from researchers at Radboud University Medical Center showing the use...
Bionano Announces First Study Using OGM to Discover Structural Variants with Potential Relevance to Genetic Diagnosis of MRKH Syndrome, a Syndrome Impacting Reproductive System Development in 1 in 4,500 Females
22. März 2023 08:00 ET
|
Bionano Genomics
Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome is among several forms of Müllerian agenesis, a disorder impacting 1 in 4,500 females which is indicated by the absence or underdevelopment of the female...
Bionano Laboratories Expands its Clinical Testing Menu with Launch of OGM-Based Laboratory Developed Tests (LDTs) for Prenatal and Postnatal Analysis
15. März 2023 08:00 ET
|
Bionano Genomics
SAN DIEGO, March 15, 2023 (GLOBE NEWSWIRE) -- Bionano Laboratories today announced the expansion of its clinical testing menu with the launch of two new laboratory developed tests (LDTs) based on...
Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Featuring OGM Utility Across a Broad Range of Research Applications
13. März 2023 08:00 ET
|
Bionano Genomics
Bionano CEO and president Dr. Erik Holmlin will participate with Dr. Bruce Korf, president of the ACMG Foundation, in the foundation’s educational and clinical laboratory genetics and genomics (LGG)...